Skip to content

Journal of Psychoactive Drugs

ISSN 0279-1072, 2159-9777

419 papers in the library · 13,118 citations · publishing 1976-2026

Papers

Sort Most recent Most cited

A Qualitative Analysis of First-Hand Accounts of Diphenhydramine Misuse Available on YouTube

Journal of Psychoactive Drugs August 31, 2023 Haley Maria Dourron, Heith Copes, Agasthya Vedre-Kyanam et al. 6 citations

Deliriants are the least studied class of hallucinogens and display noticeable subjective effects, including dysphoria, hallucinations, and substantial alterations in thought. High doses of diphenhydramine (DPH), an over-the-counter antihistamine medication, can produce deliriant effects due to secondary anticholinergic activity. We sought to characterize the subjective experiences produced by...

DOI: 10.1080/02791072.2023.2251985 (opens in new tab) Anxiety Diphenhydramine Context archaeology Thematic analysis +4

Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders

Journal of Psychoactive Drugs August 24, 2023 Stanley Wong, An Yi Yu, Nicholas Fabiano et al. 11 citations

There has been a resurgence of interest in the use of psychedelic therapies for several mental and substance use disorders. Psilocybin, a "classic" serotonergic psychedelic, has emerged as one of the primary compounds of interest in clinical research. While research on psilocybin's potential mental health benefits has grown, data on the safety and efficacy of other serotonergic psychedelics...

Seasonal Variation of Use of Common Psychedelics and Party Drugs Among Nightclub/Festival Attendees in New York City

Journal of Psychoactive Drugs August 21, 2023 Caroline Rutherford, Austin Le, Joseph J Palamar et al. 2 citations

Few epidemiological studies have focused on seasonal variation in the use of common psychedelics and party drugs among nightclub and festival attendees, typically those who attend electronic dance music (EDM) events. We sought to determine whether the use of different drug types varies seasonally within this population. Across 15 seasons from summer 2017 through fall 2022, we surveyed 3,935...

A Proposal to Study the Safety and Efficacy of Psilocybe cubensis in Preclinical and Clinical Studies as a Therapeutic Alternative for Major Depressive Disorder

Journal of Psychoactive Drugs August 18, 2023 Raul Escamilla, María Eva González-Trujano, Jesús M. González Mariscal et al. 7 citations

The pharmacological treatment of depression consists of taking antidepressant drugs for prolonged periods; its modest therapeutic effect can often be associated with significant adverse effects, while its discontinuation can lead to relapses. Psilocybin is today a novel and breakthrough therapy for major depression. It is a natural alkaloid in Psilocybe mushrooms, which are endemic to Mexico....

DOI: 10.1080/02791072.2023.2246459 (opens in new tab) Psychedelic therapy Major depression Psilocybe mushrooms Psychedelic medicine +3

On the mushrooming reports of “quiet quitting”: Employees’ lifetime psilocybin use predicts their overtime hours worked

Journal of Psychoactive Drugs July 31, 2023 Benjamin A. Korman 8 citations

Despite the recent and sharp rise in psychedelic research, few studies have investigated how classic psychedelic use relates to employees' work-related outcomes. This is surprising given that the increased use, decriminalization, and legalization of classic psychedelics in the United States (U.S.) has the potential to impact both employees and their organizations. Addressing this gap, the...

DOI: 10.1080/02791072.2023.2242358 (opens in new tab) Psilocybin Overtime Legalization Decriminalization +3

The Relationship Between Naturalistic Psychedelic Use and Clinical Care in Canada

Journal of Psychoactive Drugs July 29, 2023 Nicolas G. Glynos, Daniel J. Kruger, Nicholas Kolbman et al.

ABSTRACT Naturalistic psychedelic use among Canadians is common. However, interactions about psychedelic use between patients and clinicians in Canada remain unclear. Via an anonymous survey, we assessed health outcomes and integration of psychedelic use with health care providers (HCP) among Canadian adults reporting past use of a psychedelic. The survey included 2,384 participants, and most...

Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences

Journal of Psychoactive Drugs July 14, 2023 Christopher Timmermann, Aki Nikolaidis, Alan K. Davis et al. 4 citations

This study translated and tested the psychometric properties of acute psychedelic effects measures among Spanish-speaking people. The Psychological Insight Questionnaire (PIQ), Challenging Experiences Questionnaire (CEQ), and Mystical Experiences Questionnaire (MEQ) were translated before being incorporated into a web-based survey. We recruited native Spanish-speakers (N = 442; Mage = 30.8, SD...

DOI: 10.1080/02791072.2023.2232379 (opens in new tab) Psilocybin Confirmatory factor analysis Clinical psychology Prosocial behavior +4

Psilocybin’s Potential Mechanisms in the Treatment of Depression: A Systematic Review

Journal of Psychoactive Drugs June 29, 2023 Harrison J Lee, Vivian Wl Tsang, Brandon S Chai et al. 19 citations

Evidence suggests that psilocybin has therapeutic benefit for treating depression. However, there is little consensus regarding the mechanism by which psilocybin elicits antidepressant effects. This systematic review summarizes existing evidence. Ovid MEDLINE, EMBASE, psychINFO, and Web of Science were searched, for both human and animal studies, using a combination of MeSH Terms and free-text...

DOI: 10.1080/02791072.2023.2223195 (opens in new tab) Depression Psilocybin Mechanism of action Psychedelic treatment +5

Health Benefits and Positive Acute Effects of Psilocybin Consumption: A Quantitative Textual Analysis of User Self-Reported Data

Journal of Psychoactive Drugs June 22, 2023 Bheatrix Bienemann, Amanda Rocha Barbosa, Lucas Villar Magalhães da Cruz et al. 3 citations

There has been growth in the use of psychedelics by the global population in recent years. In addition to recreational and ritualistic use, recent research into psychedelics has brought advances for treating mental disorders. Understanding the specific circumstances in which psilocybin leads to positive outcomes may have important implications for the future of its clinical use and for harm...

Psychedelic Experiences After Bereavement Improve Symptoms of Grief: The Influence of Emotional Breakthroughs and Challenging Experiences

Journal of Psychoactive Drugs June 21, 2023 Fiona Low, Mitch Earleywine 15 citations

Grief, a common reaction to loss, can frequently become problematic or impairing. Available treatments for prolonged grief disorder are promising but leave room for considerable improvement. Qualitative accounts of psychedelic experiences after bereavement reveal themes that parallel core components of prolonged grief disorder therapy. However, few studies have investigated the therapeutic...

DOI: 10.1080/02791072.2023.2228303 (opens in new tab) Traumatic grief Psychotherapist Disenfranchised grief Clinical psychology

Psychedelic Treatments for Substance Use Disorder and Substance Misuse: A Mixed Methods Systematic Review

Journal of Psychoactive Drugs March 18, 2023 Raman Sharma, Rachel Batchelor, Jacqueline Sin 25 citations

Renewed interest in psychedelic substances in the 21st century has seen the exploration of psychedelic treatments for various psychiatric disorders including substance use disorder (SUD). This review aimed to assess the effectiveness of psychedelic treatments for people with SUD and those falling below diagnostic thresholds (i.e. substance misuse). We systematically searched 11 databases, trial...

Menstrual Changes and Reversal of Amenorrhea Induced by Classic Psychedelics: A Case Series

Journal of Psychoactive Drugs January 22, 2023 Natalie Gukasyan, Sasha K. Narayan 9 citations

ABSTRACT There has been little research on the effects of psychedelics on menstrual and reproductive function, though anecdotal evidence suggests that these compounds may have striking effects on menstrual function in at least a subset of users. Social media and word of mouth were used to seek out individuals who had a history of changes in menstrual function following psychedelic use. Case...

Educational Materials and Image Induction Increase Treatment Credibility

Journal of Psychoactive Drugs January 22, 2023 Fiona Low, Mitch Earleywine 3 citations

Patient-perceived treatment credibility is linked to important outcome measures including symptom reduction, therapeutic alliance, patient satisfaction, and attrition rates. However, few studies have tested strategies to enhance treatment credibility. The present study investigates the effect of brief, written educational materials and the use of an image induction prime on perceptions of...

DOI: 10.1080/02791072.2022.2154722 (opens in new tab) Psilocybin Credibility Clinical psychology Psychotherapist

The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Psychedelics.

Journal of Psychoactive Drugs 2023 Aviad Hadar, Jonathan David, Nadav Shalit et al. 93 citations

Psychedelics were used in the treatment of psychiatric conditions prior to their prohibition in the late 1960s. In the past three decades, there is a revived research interest in the therapeutic potential of psychedelic drugs with expected FDA approvals for treatment of various conditions. Given the exponential scientific growth of this field, we sought to characterize, analyze, and visualize...

Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States.

Journal of Psychoactive Drugs 2023 Otto Simonsson, Simon B. Goldberg 37 citations

There are neurophysiological and phenomenological overlaps between psychedelic and meditative states, but there is little evidence on how exposure to psychedelics might be associated with meditation-related variables. We assessed lifetime classic psychedelic use, ego dissolution during one's most intense experience using a classic psychedelic, and exposure to meditation in a representative...

Systematic Review of Psychometric Instruments Used in Research with Psychedelics.

Journal of Psychoactive Drugs 2023 Alexandre Augusto de Deus Pontual, H G Senhorini, C M Corradi-Webster et al. 37 citations

There has been a revival of research that studies the subjective effects of psychedelic drugs on humans. Areas of health science have been studying their possible therapeutic benefits, and psychological measurement instruments are being developed as the studies progress. However, these instruments currently suffer criticism regarding their number and evidence of psychometric quality. This study...

Contextual Parameters Associated with Positive and Negative Mental Health in Recreational Psychedelic Users.

Journal of Psychoactive Drugs 2023 Kevin O. St. Arnaud, Donald Sharpe 31 citations

Growing research exploring the utility of psychedelic substances suggests that they not only hold promise for clinical practice but may enhance mental health through recreational use as well. However, given the importance of set and setting for maximizing benefits and minimizing harms of drug use, it is important to develop a foundational understanding of the contextual factors associated with...

DOI: 10.1080/02791072.2022.2039815 (opens in new tab) Full text (opens in new tab) Psychedelics Drug policy Entheogens Harm reduction +2

"How Do I Learn More About this?": Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics.

Journal of Psychoactive Drugs 2023 Daniel J. Kruger, Oskar Enghoff, Moss Herberholz et al. 24 citations

There is a surge of interest in psychedelics, including new stakeholders and greater media attention. There is a need to examine the information-seeking behavior of people using psychedelics naturalistically, given the importance of preparation and harm-reduction. We examined sources of information for people using psychedelics naturalistically, and the degree to which they are trusted in a...

Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health.

Journal of Psychoactive Drugs 2023 Julian Urrutia, Brian T Anderson, Sean J Belouin et al. 21 citations

As individuals and communities around the world confront mounting physical, psychological, and social threats, three complimentary mind-body-spirit pathways toward health, wellbeing, and human flourishing remain underappreciated within conventional practice among the biomedical, public health, and policy communities. This paper reviews literature on psychedelic science, contemplative practices,...

DOI: 10.1080/02791072.2023.2258367 (opens in new tab) Full text (opens in new tab) Indigenous Psychedelic science Community-based Contemplative practices +4

Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials.

Journal of Psychoactive Drugs 2023 Zachary Herrmann, Mitch Earleywine, Joseph A. de Leo et al. 19 citations

Subjective responses to psychoactive drugs have served as intriguing windows into consciousness as well as useful predictors. Subjective reactions to psychedelic molecules are particularly interesting given how they covary with subsequent improvements associated with psychedelic-assisted treatments. Although links between subjective reactions and decreases in treatment-resistant clinical...

Impact of a Naturalistic Psychedelic Experience on Smoking: A Retrospective Survey.

Journal of Psychoactive Drugs 2023 Bruno Romeo, Baptiste Fauvel, S Dejean et al. 14 citations

Tobacco use disorder is a major public health concern. The aim of this study was to investigate the impact of a psychedelic experience in a natural context on tobacco use. A retrospective online survey was conducted on 173 individuals who reported having had a psychedelic experience while being smokers. Demographic information was collected, and characteristics of the psychedelic experience,...

Self-Care Practices with Psychedelics - A Qualitative Study of Users' Perspectives.

Journal of Psychoactive Drugs 2023 Carla Mendes Soares, Ângela Leite, Marta Pinto 10 citations

This article explores the psychedelic experience from the users' point of view and through the lens of self-care, a concept within the domain of health and well-being. In a time of renewed interest in psychedelic-assisted psychotherapy, we aim to contribute to a better understanding of these substances by exploring their role in different settings. A phenomenological approach was used in this...

DOI: 10.1080/02791072.2022.2071134 (opens in new tab) Full text (opens in new tab) Psychedelics Qualitative research Hallucinogens Self-care

An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically.

Journal of Psychoactive Drugs 2023 Daniel J. Kruger, Nicolas G. Glynos, Christopher W Fields et al. 10 citations

Identifying gaps and strengths in psychedelic-related knowledge is key to developing effective, evidence-based education to inform appropriate use of and harm reduction practices for psychedelics in the naturalistic use landscape. The current study piloted an assessment instrument with questions on legal status, therapeutic potential, and side effects of psychedelics among people reporting...

Therapeutic Effects of Ceremonial Ayahuasca Use for Methamphetamine Use Disorders and Other Mental Health Challenges: Case Studies in an Indigenous Community in Sonora, Mexico.

Journal of Psychoactive Drugs 2023 Anja Loizaga-Velder, Cecile Giovannetti, Ricardo Campoy Gomez et al. 9 citations

This paper describes three case studies from an outpatient intercultural therapeutic program founded and run by Yaqui health professionals and traditional healers to serve members of the Yaqui tribe residing in Sonora, Mexico. This pilot therapeutic program has been designed specifically for Indigenous individuals, incorporating the ceremonial use of naturally derived psychedelics in addressing...

"Getting to the Root": Ayahuasca Ceremony Leaders' Perspectives on Eating Disorders.

Journal of Psychoactive Drugs 2023 Meris Williams, Annie Kingston Miller, Anja Loizaga-Velder et al. 8 citations

Given the mortality, chronicity, and treatment drop-out rates observed among individuals with eating disorders (EDs), innovative approaches are needed. Ayahuasca, a psychedelic plant medicine from the Amazon, is currently being investigated. This study expands on prior exploratory research by describing the perspectives of ayahuasca ceremony leaders regarding their conceptualizations of EDs and...